While it might have given our ancestors an evolutionary advantage, an "unstable" region on human chromosome 15 is also the source of a set of inherited neurological diseases. Researchers at ...

Researchers have identified how and where in the genome a cancer chemotherapy agent acts on and "un-silences" the epigenetically silenced gene that causes Angelman syndrome, a rare neurodevelopmental ...

We read with great interest the recent Prader–Willi syndrome (PWS) and Angelman syndrome (AS) review articles by Cassidy and Driscoll (2009) 1 and by Van Buggenhout and Fryns (2009), 2 respectively.

Purpose: Considering cost as a factor, the authors evaluated three approaches to the diagnostic testing of Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Methods: The approaches evaluated ...

The research, led by the Murdoch Children's Research Institute (MCRI), reported that screening for Prader Willi, Angelman and Dup15q syndromes using the new type of test would open new avenues for ...

New research on the genetics of Prader-Willi and Angelman syndromes could help in developing personalised therapies for associated mental illness and autism features. Prader-Willi syndrome (PWS) and ...

A newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable and scalable, according to a new study. The study, published in the Journal of the ...

(Philadelphia, PA) – While it might have given our ancestors an evolutionary advantage, an "unstable" region on human chromosome 15 is also the source of a set of inherited neurological diseases.

Recent data suggest that a chemotherapy agent used to treat metastatic cancers may also be therapeutic for Angelman or Prader-Willi syndrome, according to researchers. “What determines whether you ...

Add Yahoo as a preferred source to see more of our stories on Google. The rare neurogenetic disorder affects 1 in 15,000 people For the first time, Colin Farrell has opened up his home and talked ...